For richer charts and full features, open SpikePanel on desktop.
Graded daily on value D-, growth B, profitability B-, momentum C-, revisions C-. Sector-relative, identical for every user.
Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $AXON are available with SpikePanel Pro.
Key events, in time order
New device boosts AI processing and battery life for real-time field assistance
State corrections adopt Axon body cameras; reports show 40% reduction in physical assaults on staff
Subsidiary Marrero Armor lands first international order, expanding global reach of U.S.-made ballistic protection
Company confirms pricing of offering; market concerns over dilution and debt load weigh on shares.
Q2 revenue up 35% YoY, 10th straight quarter of 30%+ growth; stock up over 30x since early 2016
Post-earnings drop attracts multiple independent investors to initiate/add positions, citing support levels
全年营收指引上调至同比增长 32%-34%，较此前 30%-32% 上调 200 个基点。
全年营收指引上调至同比增长 32%-34%，较此前 30%-32% 上调 200 个基点。
全年营收指引上调至同比增长 32%-34%，较此前 30%-32% 上调 200 个基点。
Amundi's 13F filing shows reduced position, adding to institutional selling trend
Institutional quarterly holding change reflects capital flow
Rising options IV corroborates recent large institutional inflows
Trump bought Axon stock in February; weeks later ICE sought $220M deal, raising scrutiny
None yet
None yet
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice